Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Tanox. (TNOX) -- Ignore unavailable to you. Want to Upgrade?

To: Barron Von Hymen who wrote (4)	9/18/2000 4:34:14 PM
From: Don Miller	Respond to of 10

Where did you find news of Novartis position changes? Could you give me a link? I have been in SEPR for about two years now and have remained both interested and concerned about Anti-IgE alternatives. So much so I sought out Tanox (TNOX) months before it became public this spring. I opened a discussion on VD medical portfolio last week asking for their consideration, using the links I have collected so far from your posts and elsewhere. Message 14392674 The dosage that killed the monkeys was 25X the max for E26 not E25 (according to another reporter). It looks like DNA's new releases are the place to follow this company, not even their own website is covering E25 press releases.